Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Epilepsiezentrum Kork is a premier specialized medical facility in Germany dedicated to the comprehensive diagnosis, treatment, and social rehabilitation of individuals with epilepsy. Located in Kehl-Kork and operating under the non-profit foundation Diakonie Kork, the center provides multidisciplinary care for children, adolescents, and adults through its specialized clinics and extensive outpatient departments. The institution is a major European hub for epileptology, featuring advanced diagnostic capabilities such as long-term video-EEG monitoring and high-density EEG. Beyond clinical practice, the center is heavily involved in international clinical research, participating in trials for novel anti-seizure medications and neurostimulation devices. Its holistic approach integrates medical excellence with social services, vocational training, and specialized housing for patients with complex neurological needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Epilepsiezentrum Kork.